Although the idea of blocking TNF-α seemed promising, this approach was seen to have little effect on IFP patients and was detrimental to individuals with rheumatoid arthritis who have PF [38,43,46,50,51,52]. The gene discussed is TNF; the disease is rheumatoid arthritis.